Reference Type:  Journal Article
Record Number: 525
Author: Cruchaga, C., Kauwe, J. S., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., Bertelsen, S., Bailey, M., McKean, D., Shulman, J. M., De Jager, P. L., Chibnik, L., Bennett, D. A., Arnold, S. E., Harold, D., Sims, R., Gerrish, A., Williams, J., Van Deerlin, V. M., Lee, V. M., Shaw, L. M., Trojanowski, J. Q., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Schellenberg, G. D., Peskind, E. R., Galasko, D., Fagan, A. M., Holtzman, D. M., Morris, J. C. and Goate, A. M.
Year: 2013
Title: GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease
Journal: Neuron
Volume: 78
Issue: 2
Pages: 256-68
Epub Date: 2013/04/09
Date: Apr 24
Type of Article: Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Short Title: GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease
Alternate Journal: Neuron
ISSN: 1097-4199 (Electronic)
0896-6273 (Linking)
DOI: 10.1016/j.neuron.2013.02.026
PMCID: 3664945
Accession Number: 23562540
Abstract: Cerebrospinal fluid (CSF) tau, tau phosphorylated at threonine 181 (ptau), and Abeta(4)(2) are established biomarkers for Alzheimer's disease (AD) and have been used as quantitative traits for genetic analyses. We performed the largest genome-wide association study for cerebrospinal fluid (CSF) tau/ptau levels published to date (n = 1,269), identifying three genome-wide significant loci for CSF tau and ptau: rs9877502 (p = 4.89 x 10(-)(9) for tau) located at 3q28 between GEMC1 and OSTN, rs514716 (p = 1.07 x 10(-)(8) and p = 3.22 x 10(-)(9) for tau and ptau, respectively), located at 9p24.2 within GLIS3 and rs6922617 (p = 3.58 x 10(-)(8) for CSF ptau) at 6p21.1 within the TREM gene cluster, a region recently reported to harbor rare variants that increase AD risk. In independent data sets, rs9877502 showed a strong association with risk for AD, tangle pathology, and global cognitive decline (p = 2.67 x 10(-)(4), 0.039, 4.86 x 10(-)(5), respectively) illustrating how this endophenotype-based approach can be used to identify new AD risk loci.
Notes: Cruchaga, Carlos
Kauwe, John S K
Harari, Oscar
Jin, Sheng Chih
Cai, Yefei
Karch, Celeste M
Benitez, Bruno A
Jeng, Amanda T
Skorupa, Tara
Carrell, David
Bertelsen, Sarah
Bailey, Matthew
McKean, David
Shulman, Joshua M
De Jager, Philip L
Chibnik, Lori
Bennett, David A
Arnold, Steve E
Harold, Denise
Sims, Rebecca
Gerrish, Amy
Williams, Julie
Van Deerlin, Vivianna M
Lee, Virginia M-Y
Shaw, Leslie M
Trojanowski, John Q
Haines, Jonathan L
Mayeux, Richard
Pericak-Vance, Margaret A
Farrer, Lindsay A
Schellenberg, Gerard D
Peskind, Elaine R
Galasko, Douglas
Fagan, Anne M
Holtzman, David M
Morris, John C
GERAD Consortium
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Alzheimer Disease Genetic Consortium (ADGC)
Goate, Alison M
AG010124/AG/NIA NIH HHS/
AG05136/AG/NIA NIH HHS/
K08 AG034290/AG/NIA NIH HHS/
P01 AG003991/AG/NIA NIH HHS/
P01 AG026276/AG/NIA NIH HHS/
P01 AG03991/AG/NIA NIH HHS/
P01 AG05131/AG/NIA NIH HHS/
P30 AG010161/AG/NIA NIH HHS/
P30 NS069329/NS/NINDS NIH HHS/
P30 NS069329-01/NS/NINDS NIH HHS/
P50 AG005681/AG/NIA NIH HHS/
P50 AG05681/AG/NIA NIH HHS/
R01 AG015819/AG/NIA NIH HHS/
R01 AG035083/AG/NIA NIH HHS/
R01 AG042611/AG/NIA NIH HHS/
R01 AG16208/AG/NIA NIH HHS/
U01 AG032984/AG/NIA NIH HHS/
Neuron. 2013 Apr 24;78(2):256-68. doi: 10.1016/j.neuron.2013.02.026. Epub 2013 Apr 4.
URL: http://www.ncbi.nlm.nih.gov/pubmed/23562540
Author Address: Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
Language: eng

